Literature DB >> 14580571

Metabonomics: NMR spectroscopy and pattern recognition analysis of body fluids and tissues for characterisation of xenobiotic toxicity and disease diagnosis.

Julian L Griffin1.   

Abstract

Global profiling tools are required to fully understand the impact of genetic modifications and toxicological interventions on the network of transcripts, proteins and metabolites found within a cell, tissue or organism. High-resolution 1H NMR spectroscopy in conjunction with statistical pattern recognition is one such technique, referred to as metabonomics or metabolomics, which is increasingly being used to globally profile metabolites. This review examines analytical advances in NMR spectroscopy that have aided this development including high-resolution magic angle spinning NMR spectroscopy, cryogenically cooled probes and high-through put systems. This has allowed the approach to identify genetically modified yeast strains and distinguish both disease presence and severity in coronary heart disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14580571     DOI: 10.1016/j.cbpa.2003.08.008

Source DB:  PubMed          Journal:  Curr Opin Chem Biol        ISSN: 1367-5931            Impact factor:   8.822


  57 in total

1.  Modeling the resolution and sensitivity of FAIMS analyses.

Authors:  Alexandre A Shvartsburg; Keqi Tang; Richard D Smith
Journal:  J Am Soc Mass Spectrom       Date:  2004-10       Impact factor: 3.109

2.  Revealing the metabonomic variation of EC using ¹H-NMR spectroscopy and its association with the clinicopathological characteristics.

Authors:  Ayshamgul Hasim; Hong Ma; Batur Mamtimin; Abulizi Abudula; Madiniyet Niyaz; Li-Wei Zhang; Juret Anwer; Ilyar Sheyhidin
Journal:  Mol Biol Rep       Date:  2012-06-27       Impact factor: 2.316

3.  Combining NMR and LC/MS Using Backward Variable Elimination: Metabolomics Analysis of Colorectal Cancer, Polyps, and Healthy Controls.

Authors:  Lingli Deng; Haiwei Gu; Jiangjiang Zhu; G A Nagana Gowda; Danijel Djukovic; E Gabriela Chiorean; Daniel Raftery
Journal:  Anal Chem       Date:  2016-08-01       Impact factor: 6.986

4.  Serum metabolomic profiles evaluated after surgery may identify patients with oestrogen receptor negative early breast cancer at increased risk of disease recurrence. Results from a retrospective study.

Authors:  Leonardo Tenori; Catherine Oakman; Patrick G Morris; Ewa Gralka; Natalie Turner; Silvia Cappadona; Monica Fornier; Cliff Hudis; Larry Norton; Claudio Luchinat; Angelo Di Leo
Journal:  Mol Oncol       Date:  2014-08-10       Impact factor: 6.603

5.  Tissue targeted metabonomics: metabolic profiling by microdialysis sampling and microcoil NMR.

Authors:  Kristin E Price; Shannon S Vandaveer; Craig E Lunte; Cynthia K Larive
Journal:  J Pharm Biomed Anal       Date:  2005-08-10       Impact factor: 3.935

6.  Diagnosing diabetic nephropathy by 1H NMR metabonomics of serum.

Authors:  Ville-Petteri Mäkinen; Pasi Soininen; Carol Forsblom; Maija Parkkonen; Petri Ingman; Kimmo Kaski; Per-Henrik Groop; Mika Ala-Korpela
Journal:  MAGMA       Date:  2006-12-15       Impact factor: 2.310

7.  Comparison of analytical mathematical approaches for identifying key nuclear magnetic resonance spectroscopy biomarkers in the diagnosis and assessment of clinical change of diseases.

Authors:  Jason B Nikas; C Dirk Keene; Walter C Low
Journal:  J Comp Neurol       Date:  2010-10-15       Impact factor: 3.215

Review 8.  Application of metabonomic analytical techniques in the modernization and toxicology research of traditional Chinese medicine.

Authors:  Yong-Min Lao; Jian-Guo Jiang; Lu Yan
Journal:  Br J Pharmacol       Date:  2009-06-05       Impact factor: 8.739

Review 9.  New tools and new biology: recent miniaturized systems for molecular and cellular biology.

Authors:  Morgan Hamon; Jong Wook Hong
Journal:  Mol Cells       Date:  2013-12-02       Impact factor: 5.034

10.  Globally Optimized Targeted Mass Spectrometry: Reliable Metabolomics Analysis with Broad Coverage.

Authors:  Haiwei Gu; Ping Zhang; Jiangjiang Zhu; Daniel Raftery
Journal:  Anal Chem       Date:  2015-12-02       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.